Coronary Other
Payments companies reported to CMS as associated with Coronary Other. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Coronary Other, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Coronary Other
These are the largest totals companies reported as associated with Coronary Other. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $17,819.50 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $3,727.98 |
| Prashanth Thakker | Saint Louis, MO | Interventional Cardiology | $2,517.91 |
| Ramy Badawi | Kailua, HI | Cardiovascular Disease | $2,311.12 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $1,985.36 |
| Kris Kawamoto | Honolulu, HI | Interventional Cardiology | $1,967.82 |
| Bruce Samuels | Beverly Hills, CA | Cardiovascular Disease | $1,689.70 |
| Mohammad Hashmi | San Luis Obispo, CA | Interventional Cardiology | $1,620.28 |
| Sriya Avadhani | Brooklyn, NY | Interventional Cardiology | $1,579.91 |
| Manoj Kesarwani | Sacramento, CA | Interventional Cardiology | $1,575.64 |
Prescribed Coronary Other?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.